3 Ways The FDA Is Taking Action On Lack Of Diversity In Cancer Clinical Trials
Beyond issuing guidance documents, what actions has the FDA taken to ensure inclusion of relevant patient populations in cancer clinical trials? And...
Source: clinicalleader.com